
\begin{table*}[!tbp]
\small
\caption{Confusion tables for the REGS classifiers.
Reference based normalisation shown in the rows and cohort normalisation in the columns.\label{tab:confusiondrugreference}}
\begin{center}
\begin{tabular}{lrrrcrrrcrrrcrrr}
\hline\hline
\multicolumn{1}{l}{\bfseries  }&\multicolumn{3}{c}{\bfseries MDFCI}&\multicolumn{1}{c}{\bfseries }&\multicolumn{3}{c}{\bfseries IDRC}&\multicolumn{1}{c}{\bfseries }&\multicolumn{3}{c}{\bfseries LLMPP RCHOP}&\multicolumn{1}{c}{\bfseries }&\multicolumn{3}{c}{\bfseries CHEPRETRO}\tabularnewline
\cline{2-4} \cline{6-8} \cline{10-12} \cline{14-16}
\multicolumn{1}{l}{}&\multicolumn{1}{c}{Sen}&\multicolumn{1}{c}{Int}&\multicolumn{1}{c}{Res}&\multicolumn{1}{c}{}&\multicolumn{1}{c}{Sen}&\multicolumn{1}{c}{Int}&\multicolumn{1}{c}{Res}&\multicolumn{1}{c}{}&\multicolumn{1}{c}{Sen}&\multicolumn{1}{c}{Int}&\multicolumn{1}{c}{Res}&\multicolumn{1}{c}{}&\multicolumn{1}{c}{Sen}&\multicolumn{1}{c}{Int}&\multicolumn{1}{c}{Res}\tabularnewline
\hline
{\bfseries Cyclophosphamide}&&&&&&&&&&&&&&&\tabularnewline
~~Sensitive&$15$&$ 0$&$ 0$&&$ 82$&$  3$&$  0$&&$68$&$25$&$ 0$&&$18$&$ 5$&$ 0$\tabularnewline
~~Intermediate&$ 2$&$19$&$ 0$&&$ 20$&$137$&$  0$&&$ 0$&$43$&$21$&&$ 0$&$20$&$ 5$\tabularnewline
~~Resistant&$ 0$&$ 7$&$17$&&$  0$&$ 37$&$161$&&$ 0$&$ 0$&$46$&&$ 0$&$ 0$&$11$\tabularnewline
\hline
{\bfseries Doxorubicin}&&&&&&&&&&&&&&&\tabularnewline
~~Sensitive&$12$&$ 0$&$ 0$&&$120$&$ 21$&$  0$&&$70$&$10$&$ 0$&&$14$&$ 0$&$ 0$\tabularnewline
~~Intermediate&$ 6$&$15$&$ 0$&&$ 11$&$126$&$  5$&&$ 0$&$57$&$11$&&$ 2$&$15$&$ 0$\tabularnewline
~~Resistant&$ 0$&$ 4$&$23$&&$  0$&$ 16$&$141$&&$ 0$&$ 0$&$55$&&$ 0$&$ 6$&$22$\tabularnewline
\hline
{\bfseries Vincristine}&&&&&&&&&&&&&&&\tabularnewline
~~Sensitive&$12$&$ 0$&$ 0$&&$152$&$ 49$&$  3$&&$60$&$ 3$&$ 0$&&$17$&$ 0$&$ 0$\tabularnewline
~~Intermediate&$ 8$&$ 9$&$ 0$&&$  0$&$ 86$&$ 40$&&$ 9$&$49$&$ 2$&&$ 2$&$11$&$ 0$\tabularnewline
~~Resistant&$ 0$&$ 8$&$23$&&$  0$&$  6$&$104$&&$ 0$&$10$&$70$&&$ 0$&$ 4$&$25$\tabularnewline
\hline
{\bfseries Combined}&&&&&&&&&&&&&&&\tabularnewline
~~Sensitive&$13$&$ 0$&$ 0$&&$117$&$ 12$&$  0$&&$70$&$14$&$ 0$&&$16$&$ 0$&$ 0$\tabularnewline
~~Intermediate&$ 7$&$10$&$ 0$&&$  5$&$146$&$  8$&&$ 0$&$54$&$13$&&$ 0$&$18$&$ 0$\tabularnewline
~~Resistant&$ 0$&$ 6$&$24$&&$  0$&$ 15$&$137$&&$ 0$&$ 0$&$52$&&$ 0$&$ 4$&$21$\tabularnewline
\hline
\end{tabular}
\end{center}
\end{table*}
